logowsbdaily | Mon, 26 Sep 2022 03:58:40 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Cassava Sciences, Inc.
(SAVA)

Cassava Sciences, Inc.
7801 North Capital of Texas Highway
Suite 260
Austin, TX 78731
United States
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc.... Read More

Summary & Charts

Price$ 41.87-9.19 (-18%)
Day's Range$ 38.11 - 44.62 
Previous Close$ 51.06
Market Cap$ 1.68B USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqCM
IndustryBiotechnology
SectorHealthcare
Volume13.83M
Avg. Volume (20 day)4.25M
Rel. Volume (20 day)3.26
Rel. Volume (3 month)4.22
RatingB+Buy
DCFN/AStrong Buy
Debt/Equity2.99 %Neutral
ROE-17.93 %Neutral
ROA-19.07 %Neutral
P/E-36.07 %Strong Sell
P/B7.06 %Strong Buy
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Sep 23, 2022$ 38.35$ 44.62$ 38.11$ 41.87-9.1913,831,8343.264.2242
Sep 22, 2022$ 37.92$ 51.59$ 36.88$ 51.06+13.4223,647,6276.387.75107
Sep 21, 2022$ 37.71$ 41.24$ 36.11$ 37.64-1.277,190,5922.682.697
Sep 20, 2022$ 30.01$ 39.73$ 29.70$ 38.91+8.617,564,7833.082.9435
Sep 19, 2022$ 30.68$ 31.23$ 29.70$ 30.30-0.741,149,1610.530.461
Sep 16, 2022$ 31.00$ 32.44$ 30.20$ 31.04-0.541,258,0970.560.521
Sep 15, 2022$ 32.80$ 33.60$ 31.54$ 31.58-1.341,128,7020.360.473
Sep 14, 2022$ 30.56$ 33.03$ 29.51$ 32.92+2.051,748,0070.360.742
Sep 13, 2022$ 32.00$ 35.58$ 30.82$ 30.87-2.512,707,5810.561.155
Sep 12, 2022$ 34.39$ 34.40$ 31.82$ 33.38+0.581,711,6890.360.703
Sep 09, 2022$ 30.08$ 33.50$ 29.50$ 32.80+3.193,322,6400.701.3810
Sep 08, 2022$ 29.55$ 30.13$ 28.55$ 29.61+0.291,268,5960.270.532
Sep 07, 2022$ 28.15$ 30.80$ 28.01$ 29.32+0.962,415,7240.521.005
Sep 06, 2022$ 25.04$ 28.72$ 25.04$ 28.36+3.682,951,4290.651.2212
Sep 02, 2022$ 25.50$ 25.52$ 24.40$ 24.68-0.66933,9870.200.394
Sep 01, 2022$ 25.56$ 25.92$ 24.91$ 25.34-0.391,011,9050.220.423
Aug 31, 2022$ 26.09$ 26.49$ 24.82$ 25.73-0.511,161,3260.250.474
Aug 30, 2022$ 26.82$ 27.44$ 25.08$ 26.24+0.121,870,2500.390.7611
Aug 29, 2022$ 28.58$ 30.30$ 25.17$ 26.12-3.273,364,2210.701.368
Aug 26, 2022$ 30.12$ 30.34$ 28.10$ 29.39+2.114,671,0350.971.9013

News

The latest news about Cassava Sciences, Inc. (SAVA).

InvestorPlace | 2022-09-23 14:14:27
Shares of Cassava Sciences (NASDAQ: SAVA ) are down by over 15% following the previous day's gain of 35%. Yesterday, the Securities and Exchange Commission (SEC) announced that it had closed its case on Cassava.
Seeking Alpha | 2022-09-22 17:44:00
Initiation of a phase 3 program open-label extension study using Simufilam for patients with Alzheimer's Disease is expected in 2nd half of 2022. An ongoing long-term open label study, initiated in March of 2020 is ongoing; Dosing completion is expected Q4 of 2022 and results from it are expected before end of 2022.
InvestorPlace | 2022-09-22 16:45:37
Deleted: Despite a significant down day for the S&P 500, shares of Cassava Sciences (NASDAQ: SAVA ) closed higher by 35%. That's because the Securities and Exchange Commission (SEC) has closed its case on Cassava following the initiation of an investigation last November.
Investors Business Daily | 2022-09-22 15:06:54
The SEC reportedly cleared an investigation into Cassava Sciences, leading SAVA stock to hit a seven-month high Thursday. The post Cassava Skyrockets After SEC Clears It Of Tampering With Alzheimer's Data appeared first on Investor's Business Daily.
Seeking Alpha | 2022-09-22 08:00:00
Cassava Sciences increased by over 10% intraday on positive SEC news. Cassava Sciences is up 26% in the last month while the market is down 7%.
InvestorPlace | 2022-09-21 09:36:01
Cassava Sciences (NASDAQ: SAVA ) stock rose nearly 30% on Sept. 20 as speculators bet on the company's efforts against Alzheimer's Disease.
GlobeNewsWire | 2022-09-08 09:15:00
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, announced today that it has been invited to present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held in New York.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2022-11-08BMO-0.48----------
2022-08-03BMO-0.43-0.4811.62%------
2022-05-05BMO-0.41-0.447.31%------
2022-02-28BMO-0.33-0.356.06%------
2021-11-10BMO-0.17-0.2441.17%------
2021-08-03BMO-0.11-0.1318.18%------
2021-04-21BMO-0.1-0.0910%------
2020-11-09BMO-0.07-0.0614.29%------

Top Discussions

These are the top discussions over the last 24-hours that mention the SAVA stock ticker symbol.

Weekend Discussion Thread for the Weekend of September 24, 2022

**Read [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide), follow [Twitter](https://twitter.com/Official_WSB) and [IG](https://www.instagram.com/official_wallstreetbets/), join [Discor... Read More

19,876 comments | 0 votes


Unusual Option Activity

Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.

TypeStrikeExp DateDTEBidAskLastVolumeOpen InterestVol/OIIV
CALL$ 42.0009/29/225$ 4.05$ 4.55$ 4.241,2342415.121.89%
CALL$ 43.0009/29/225$ 3.65$ 4.15$ 3.753041831.661.90%
CALL$ 44.0009/29/225$ 3.25$ 3.85$ 3.40294466.391.92%
CALL$ 45.0009/29/225$ 3.10$ 3.50$ 3.251,9975563.591.97%
CALL$ 48.0009/29/225$ 2.22$ 2.78$ 2.573092101.472.01%
CALL$ 50.0009/29/225$ 1.86$ 2.37$ 2.103,5582,0431.742.06%
CALL$ 55.0009/29/225$ 1.00$ 1.71$ 1.351,5441,2321.252.13%
PUT$ 35.0009/29/225$ 1.52$ 1.89$ 1.701,4084693.002.03%
CALL$ 41.0010/06/2212$ 5.30$ 6.30$ 5.6520131.541.66%
CALL$ 42.0010/06/2212$ 4.90$ 5.65$ 6.0861242.541.64%
PUT$ 25.0010/06/2212$ 0.50$ 0.71$ 0.652721881.452.05%
PUT$ 34.0010/06/2212$ 2.13$ 2.88$ 3.2016111.451.90%
PUT$ 30.0010/13/2219$ 1.70$ 2.30$ 2.31128423.051.84%
CALL$ 22.5010/20/2226$ 18.20$ 20.10$ 21.8350172.941.78%
PUT$ 150.0001/19/23117$ 113.00$ 118.00$ 120.7020111.822.23%
PUT$ 22.5001/18/24481$ 10.60$ 11.05$ 10.25110831.331.49%
Last Updated: Fri, 23 Sep 2022 22:54 EST

Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Tue, 14 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.